Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Kun Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3822-2891; OpenAlex author ID A5060050239. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper

Papers 4

  1. Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells. Co-author DOI 10.1111/cas.13315↗
  2. Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12253-015-9930-y↗
  3. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer. Co-author DOI 10.3892/mmr.2014.2558↗
  4. [Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied in advanced pancreatic cancer]. Co-author PMID 22177442↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weijia Sun · 3 shared papers, 2014–2017 · strength 0.18
  2. Kemin Wu · 2 shared papers, 2014–2015 · strength 0.11
  3. Yebin Lu · 1 shared paper, 2017 · strength 0.08
  4. Hongxi Chen · 1 shared paper, 2017 · strength 0.08
  5. Guo‐Huang Hu · 1 shared paper, 2015 · strength 0.06
  6. Jian Li · 1 shared paper, 2015 · strength 0.06
  7. Jian Li · 1 shared paper, 2014 · strength 0.05
  8. Wei-jia Sun · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.